Role of the general practitioner in the care of BRCA1 and BRCA2 mutation carriers: General practitioner and patient perspectives.

ABSTRACT:

Background

General practitioners (GPs) have an increasing role in referring patients with putative mutation in BRCA1/2 genes for genetics consultation and for long-term follow-up of mutation carriers.

Methods

We compared the expectations of the GPs' role according to BRCA1/2 mutation carriers and to GPs themselves.

Results

Overall, 38% (58/152) of eligible GPs and 70% (176/252) of eligible patients were surveyed. Although 81% of GPs collected the family history, only 24% considered that they know criteria indicating genetics consultation and 39% sufficient knowledge of BRCA1/2 guidelines to answer patients' questions. Twelve% of GPs were aware of the French national guidelines. Among unsatisfied patients, 40% felt that their GP was able to answer (moderately, sufficie

SUBMITTER: Vande Perre P 

PROVIDER: S-EPMC6305637 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature